Literature DB >> 32878836

Hyponatraemia compounding pre-eclamptic toxaemia in a patient with type 1 diabetes.

Emily Briggs1, Orene Greer2,3, Nishel Mohan Shah2,3, Natasha Singh2.   

Abstract

We report a case of profound, symptomatic hyponatraemia in association with pre-eclamptic toxaemia (PET) in a 38-year-old nulliparous woman with type 1 diabetes mellitus. This patient developed hypertension and proteinuria at 31+6 weeks' gestation and was admitted for management of pre-eclampsia. Severe headache, visual disturbance and nausea were associated with a hyponatraemia of 115 mmol/L followed by ketoacidosis. This was reversed through fluid restriction, supplementation with 1.8%-3.0% hypertonic saline and a volume-reduced variable-rate insulin infusion. Clinical stability was achieved and she was subsequently worked up for an induction of labour for worsening pre-eclampsia. Hyponatraemia in the context of PET has been previously reported as rare. However, it has complications that may significantly compound the sequelae of severe PET. We propose that specific and focused monitoring of serum sodium levels should become common practice in the management of women with this condition to allow for timely, measured correction of abnormalities. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diabetes; endocrinology; obstetrics and gynaecology

Mesh:

Substances:

Year:  2020        PMID: 32878836      PMCID: PMC7470496          DOI: 10.1136/bcr-2020-236511

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  35 in total

1.  Severe hyponatraemia and pre-eclampsia.

Authors:  Celia Burrell; Michael de Swiet
Journal:  BJOG       Date:  2004-09       Impact factor: 6.531

Review 2.  Neurological counterparts of hyponatremia: pathological mechanisms and clinical manifestations.

Authors:  Manuel Alfredo Podestà; Irene Faravelli; David Cucchiari; Francesco Reggiani; Silvia Oldani; Carlo Fedeli; Giorgio Graziani
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

3.  Serum Vasopressinase and Platelet Responses to Arginine Vasopressin in Normal Pregnancy, Pregnancy-induced Hypertension and Pre-eclampsia.

Authors:  M P Gordge; S C Robson; D J Williams; N N Payne; G H Neild
Journal:  Platelets       Date:  1994       Impact factor: 3.862

4.  Pathophysiology and management of preeclampsia-associated severe hyponatremia.

Authors:  Gagangeet Sandhu; Senthil Ramaiyah; Germaine Chan; Ira Meisels
Journal:  Am J Kidney Dis       Date:  2009-12-11       Impact factor: 8.860

5.  Clinical practice guideline on diagnosis and treatment of hyponatraemia.

Authors:  Goce Spasovski; Raymond Vanholder; Bruno Allolio; Djillali Annane; Steve Ball; Daniel Bichet; Guy Decaux; Wiebke Fenske; Ewout J Hoorn; Carole Ichai; Michael Joannidis; Alain Soupart; Robert Zietse; Maria Haller; Sabine van der Veer; Wim Van Biesen; Evi Nagler
Journal:  Eur J Endocrinol       Date:  2014-02-25       Impact factor: 6.664

Review 6.  Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth.

Authors:  Devender Roberts; Julie Brown; Nancy Medley; Stuart R Dalziel
Journal:  Cochrane Database Syst Rev       Date:  2017-03-21

7.  Hyponatraemia at hospital admission is a predictor of overall mortality.

Authors:  L Balling; F Gustafsson; J P Goetze; M Dalsgaard; H Nielsen; S Boesgaard; M Bay; V Kirk; O W Nielsen; L Køber; K Iversen
Journal:  Intern Med J       Date:  2015-02       Impact factor: 2.048

8.  Hyponatremia and preeclampsia.

Authors:  Dorit Ravid; Lacra-Elena Massarwa; Tal Biron-Shental; Moshe D Fejgin
Journal:  J Matern Fetal Neonatal Med       Date:  2005-07

9.  Severe hyponatremia associated with pre-eclampsia.

Authors:  Carlos R Camara-Lemarroy; Alejandro de Leon-Cruz; Rene Rodriguez-Gutierrez; Dionicio A Galarza-Delgado
Journal:  Gynecol Endocrinol       Date:  2013-05-24       Impact factor: 2.260

10.  Syndrome of inappropriate ADH secretion in a woman with preeclampsia.

Authors:  H J Wilson; L E Shutt
Journal:  Int J Obstet Anesth       Date:  2007-07-20       Impact factor: 2.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.